Retinol (vitamin A) and riboflavin (vitamin B2) administration and metabolism in very low birth weight infants.
The combination of marginal hepatic retinol stores at delivery and the reduction of daily retinol dose due to complications with the delivery system places the VLBW infant receiving parenteral nutrition at high risk for retinol deficiency during the first month of life. This has serious health implications because retinol is essential during this period for normal growth and repair of the pulmonary tissue in VLBW infants. Enterally fed VLBW infants, on the other hand, receive relatively higher doses of retinol from vitamin-supplemented premature infant formula and fortified breast milk. Equally serious is the problem of monitoring vitamin A status in infants receiving supplemental doses of vitamin A. It seems clear that while plasma vitamin A levels are the most easily available method of monitoring vitamin A status, further studies are necessary to determine if these levels correlate with hepatic content. This is of particular concern since liver disease is common in VLBW infants and vitamin A hepatotoxicity has been described in a cohort of 41 patients receiving therapeutic doses of the vitamin. While further research of daily enteral and parenteral retinol requirements of VLBW infants should continue, formulation of a specific VLBW parenteral vitamin supplement should also be developed.
Porcelli
P J
PJ
Department of Pediatrics, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157.
Greene
H L
HL
Adcock
E W
EW
D036861:Delivery, Obstetric; D004750:Enteral Nutrition; D006801:Humans; D007230:Infant, Low Birth Weight / Q000378:metabolism*; D007231:Infant, Newborn; D008099:Liver / Q000378:metabolism; D010288:Parenteral Nutrition; D010789:Phototherapy; D012256:Riboflavin / Q000008:administration & dosage* / Q000378:metabolism / Q000528:radiation effects; D014801:Vitamin A / Q000008:administration & dosage* / Q000378:metabolism
D014801:Vitamin A; D012256:Riboflavin